DZ270A1 - Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant. - Google Patents

Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant.

Info

Publication number
DZ270A1
DZ270A1 DZ816110A DZ816110A DZ270A1 DZ 270 A1 DZ270 A1 DZ 270A1 DZ 816110 A DZ816110 A DZ 816110A DZ 816110 A DZ816110 A DZ 816110A DZ 270 A1 DZ270 A1 DZ 270A1
Authority
DZ
Algeria
Prior art keywords
active principle
coating
new
principle
amentous
Prior art date
Application number
DZ816110A
Other languages
English (en)
French (fr)
Inventor
Jasques Ser
Jean Claude Rineau
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Application granted granted Critical
Publication of DZ270A1 publication Critical patent/DZ270A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DZ816110A 1980-02-26 1981-02-25 Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant. DZ270A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8004199A FR2476485A1 (fr) 1980-02-26 1980-02-26 Nouveau procede d'enrobage d'au moins un principe actif medicamenteux, les nouveaux medicaments ainsi obtenus, et les compositions les renfermant

Publications (1)

Publication Number Publication Date
DZ270A1 true DZ270A1 (fr) 2004-09-13

Family

ID=9238982

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ816110A DZ270A1 (fr) 1980-02-26 1981-02-25 Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant.

Country Status (9)

Country Link
EP (1) EP0036345B1 (ko)
JP (1) JPS56133214A (ko)
AT (1) ATE4957T1 (ko)
CA (1) CA1163923A (ko)
DE (1) DE3161148D1 (ko)
DZ (1) DZ270A1 (ko)
FR (1) FR2476485A1 (ko)
MA (1) MA19084A1 (ko)
OA (1) OA06747A (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912146A (en) * 1985-01-30 1990-03-27 Warner-Lambert Company Coated dosage forms
US4971791A (en) * 1985-08-26 1990-11-20 The Procter & Gamble Company Taste masking compositions
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
DE4328069A1 (de) * 1993-08-20 1995-02-23 Henning Berlin Gmbh Mikropartikel, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln
ITPD20070274A1 (it) * 2007-08-08 2009-02-09 Sanypet S P A Crocchetta per animali e metodo per la sua produzione

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2010110A1 (de) * 1970-03-04 1971-09-16 Farbenfabriken Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von Mikrokapseln mit Hilfe von synthetischen Koazervaten
US3922379A (en) * 1973-12-17 1975-11-25 Abbott Lab Microencapsulation process
LU72439A1 (ko) * 1975-05-09 1977-02-09
JPS5394274A (en) * 1977-01-29 1978-08-18 Ricoh Co Ltd Micro-encapsulating method

Also Published As

Publication number Publication date
EP0036345A1 (fr) 1981-09-23
MA19084A1 (fr) 1981-10-01
ATE4957T1 (de) 1983-10-15
CA1163923A (fr) 1984-03-20
JPS56133214A (en) 1981-10-19
FR2476485B1 (ko) 1983-03-04
OA06747A (fr) 1982-06-30
EP0036345B1 (fr) 1983-10-12
FR2476485A1 (fr) 1981-08-28
JPH0530805B2 (ko) 1993-05-11
DE3161148D1 (en) 1983-11-17

Similar Documents

Publication Publication Date Title
DZ473A1 (fr) Dérivés de l'acide cis-endo-2-azabicyclo/3,3,o/-octane-3-carboxylique, procédé pour leur préparation, agents contenant ces dérivés et leur utilisation.
FR2331375A1 (fr) Procede pour l'obtention de preparations avec liberation reglee d'un principe actif
AU527784B2 (en) Treatment of thromboembolic conditions withall-z)-5, 8, 11, 14, 17-eicosapentaenoic acid
DZ593A1 (fr) Résinate d'un acide carboxylique substitué, procédé pour sa préparation, son utilisation et compositions pharmaceutiques le contenant.
DZ270A1 (fr) Nouveau procédé d'enrobage d'au moins un principe actif midécamenteux, les nouveaux médivaments ainsi obtenus et les compositions les renfermant.
ATE26213T1 (de) Aeusserlich anzuwendende arzneimittelzubereitung enthaltend adenosin zur behandlung von herpes.
JPS5781411A (en) Medicinal composition having antiviral action
OA06201A (fr) Procédé de préparation de nouveaux composés d'urée et amido .
DK0380950T3 (da) Fremgangsmåde til fremstilling af et bismuthbaseret præparat samt det aktive produkt i præparat
FR2532647B1 (fr) Thioesters d'acide acetylsalicylique, procede pour les preparer et compositions pharmaceutiques qui en renferment
FR2507605B1 (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques preparees avec ces esters
FR2441617A1 (fr) Nouveaux derives de s-triazine, leur procede de preparation et compositions pharmaceutiques les contenant
FR2522266B1 (fr) Procede de preparation d'un agent fibrinolytiquement actif et agent obtenu
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
BE878836A (fr) Derives d'acide hydroxamique, leur procede de preparation et medicament les contenant
JPS54132520A (en) Preparation of colorless methionine
FR2510577B1 (fr) Composes organiques azotes extraits de plantes et leurs derives, leur preparation et leurs utilisations therapeutiques, notamment en tant qu'agents antineoplastiques
PT77767B (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
FR2355839A1 (fr) Derives optiquement actifs d'acide benzoxazolyl-propionique, procede pour leur preparation et compositions therapeutiques les contenant
ES531260A0 (es) Procedimiento de preparar agentes farmaceuticos bactericidas utilizables contra la rinitis atrofica.
PT64821B (fr) Procede pour la preparation d'esteres pirimidin(2)iliques de l'acide thionophosphorique a effet insecticide et acaricide.
FR2430949A1 (fr) Nouvelles 4h-s-triazolo (3,4c) thieno (2,3e) 1,4-diazepines, procedes pour leur preparation et medicaments les renfermant
PT71726B (fr) Procede pour la preparation de compositions herbicides contenant comme agent actif tyocarbamattes triazynes cloroacetanilydes et urees ou ses melanges ayant comme antidote des derives cycliques de l'acide dicarboxilyque
FR2439180A1 (fr) Procede pour la preparation des derives nitro-5 et 6 de la tetrahydro-1,2,3,4 anthraquinone a partir de l'hexahydro-1,2,3,4,4a,9a anthracene-dione-9,10
GT197855468A (es) 4-deoxi-4" acilamido-derivados de oleandomicina eritromicinay carbonato de eritromicina